About
EmCyte Corporation is a leader in regenerative medicine, focusing on platelet-rich plasma (PRP) and progenitor stem cell biologics. Founded by Patrick Pennie, an experienced nurse and perfusionist, the company has developed advanced technologies that enhance autologous biologic therapies, which utilize a patient’s own cells to promote healing. The company offers the PURE® SupraPhysiologic Concentrating Systems and the Centrepid Platelet Concentrator, which allow healthcare providers to create tailored biologic formulations. These systems produce biologics rich in growth factors, multipotent stem cells, and fibrin scaffolding, supporting critical processes like tissue repair and regeneration. EmCyte serves a wide range of healthcare providers, including those in orthopedics and wound care, and emphasizes strong clinical support and training for optimal use of its technologies. Headquartered in Fort Myers, Florida, EmCyte operates from a state-of-the-art 30,000-square-foot facility that includes manufacturing, clinical treatment areas, and training spaces, all dedicated to fostering innovation and improving clinical outcomes.
Technologies
Keywords
Company Information
-
Employees 19
-
Founded 2000
-
Annual Revenue $10000000
Location
4331 Veronica S Shoemaker Blvd, Fort Myers, Florida, United States, 33916-2216
